Review




Structured Review

Simcyp prediction full pbpk method 2
The workflow of developing and validating the atomoxetine <t>full-PBPK</t> model and extrapolating the validated model to predict atomoxetine disposition in different ethnicities, special populations, and DDIs.
Prediction Full Pbpk Method 2, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prediction+full+pbpk+method+2/method+2/pmc05637815-11-7-6
Average 90 stars, based on 1 article reviews
prediction full pbpk method 2 - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions "

Article Title: Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions

Journal: Drug Metabolism and Disposition

doi: 10.1124/dmd.117.076455

The workflow of developing and validating the atomoxetine full-PBPK model and extrapolating the validated model to predict atomoxetine disposition in different ethnicities, special populations, and DDIs.
Figure Legend Snippet: The workflow of developing and validating the atomoxetine full-PBPK model and extrapolating the validated model to predict atomoxetine disposition in different ethnicities, special populations, and DDIs.

Techniques Used:

Physicochemical and PK parameters of atomoxetine used in the  PBPK  model development
Figure Legend Snippet: Physicochemical and PK parameters of atomoxetine used in the PBPK model development

Techniques Used: Molecular Weight, Recombinant

Related Articles

other:


Molecular Weight:

Article Title: Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions
Article Snippet: .. The predicted volume of distribution at steady state (Vss) value was 0.74 l/kg, compared with the observed atomoxetine Vss value of 1.02–1.09 l/kg ( Center for Drug Evaluation and Research, 2002 ) following intravenous dosing in healthy subjects. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Parameter Value Reference Physicochemical Molecular Weight (g/mol) 255.36 Stattera NDA Log P 3.9 NDA p K a 9.8 NDA f u 0.025 NDA B/P 0.623 Simcyp prediction toolbox Absorption F a 0.96 k a (l/h) 1.2 Optimized Q gut (l/h) 11.9 Simcyp prediction toolbox Distribution V ss (l/kg) 0.74 Simcyp prediction full PBPK method 2 Metabolism/elimination CL i.v. (l/h) 16.3 NDA CL r (l/h) 0.185 Sauer et al. (2003) f m,CYP2D6 0.876 Recombinant CL int ( μ l/min/pmol) CYP2D6 25.4 CYP2C19 1.84 P450 enzyme abundance (pmol/mg microsomal protein) CYP2D6 EM 8 (61) a Simcyp default value CYP2C19 EM 14 (40) a Optimized Interaction CYP2D6 K i ( μ M) 34.3 Sauer et al. (2004) CYP3A4 K i ( μ M) 3.6 Sauer et al. (2004) Open in a separate window B/P, blood-to-plasma ratio; CL i.v. , clearance after intravenous administration; CL r , renal clearance; F a , fraction absorbed; f m , fraction metabolized; f u , fraction unbound in plasma; k a , absorption rate constant; K i , inhibition constant; Log P, log octanol:water partition coefficient; Q gut , drug absorption flow to intestine; V ss , volume of distribution at steady state. a Mean value (coefficient of variance). .. Physicochemical and PK parameters of atomoxetine used in the PBPK model development Simulation of Atomoxetine Disposition and Validation of the Atomoxetine PBPK Model. All simulations were performed using the Simcyp population-based simulator and a full PBPK model.

Recombinant:

Article Title: Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions
Article Snippet: .. The predicted volume of distribution at steady state (Vss) value was 0.74 l/kg, compared with the observed atomoxetine Vss value of 1.02–1.09 l/kg ( Center for Drug Evaluation and Research, 2002 ) following intravenous dosing in healthy subjects. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Parameter Value Reference Physicochemical Molecular Weight (g/mol) 255.36 Stattera NDA Log P 3.9 NDA p K a 9.8 NDA f u 0.025 NDA B/P 0.623 Simcyp prediction toolbox Absorption F a 0.96 k a (l/h) 1.2 Optimized Q gut (l/h) 11.9 Simcyp prediction toolbox Distribution V ss (l/kg) 0.74 Simcyp prediction full PBPK method 2 Metabolism/elimination CL i.v. (l/h) 16.3 NDA CL r (l/h) 0.185 Sauer et al. (2003) f m,CYP2D6 0.876 Recombinant CL int ( μ l/min/pmol) CYP2D6 25.4 CYP2C19 1.84 P450 enzyme abundance (pmol/mg microsomal protein) CYP2D6 EM 8 (61) a Simcyp default value CYP2C19 EM 14 (40) a Optimized Interaction CYP2D6 K i ( μ M) 34.3 Sauer et al. (2004) CYP3A4 K i ( μ M) 3.6 Sauer et al. (2004) Open in a separate window B/P, blood-to-plasma ratio; CL i.v. , clearance after intravenous administration; CL r , renal clearance; F a , fraction absorbed; f m , fraction metabolized; f u , fraction unbound in plasma; k a , absorption rate constant; K i , inhibition constant; Log P, log octanol:water partition coefficient; Q gut , drug absorption flow to intestine; V ss , volume of distribution at steady state. a Mean value (coefficient of variance). .. Physicochemical and PK parameters of atomoxetine used in the PBPK model development Simulation of Atomoxetine Disposition and Validation of the Atomoxetine PBPK Model. All simulations were performed using the Simcyp population-based simulator and a full PBPK model.

Clinical Proteomics:

Article Title: Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions
Article Snippet: .. The predicted volume of distribution at steady state (Vss) value was 0.74 l/kg, compared with the observed atomoxetine Vss value of 1.02–1.09 l/kg ( Center for Drug Evaluation and Research, 2002 ) following intravenous dosing in healthy subjects. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Parameter Value Reference Physicochemical Molecular Weight (g/mol) 255.36 Stattera NDA Log P 3.9 NDA p K a 9.8 NDA f u 0.025 NDA B/P 0.623 Simcyp prediction toolbox Absorption F a 0.96 k a (l/h) 1.2 Optimized Q gut (l/h) 11.9 Simcyp prediction toolbox Distribution V ss (l/kg) 0.74 Simcyp prediction full PBPK method 2 Metabolism/elimination CL i.v. (l/h) 16.3 NDA CL r (l/h) 0.185 Sauer et al. (2003) f m,CYP2D6 0.876 Recombinant CL int ( μ l/min/pmol) CYP2D6 25.4 CYP2C19 1.84 P450 enzyme abundance (pmol/mg microsomal protein) CYP2D6 EM 8 (61) a Simcyp default value CYP2C19 EM 14 (40) a Optimized Interaction CYP2D6 K i ( μ M) 34.3 Sauer et al. (2004) CYP3A4 K i ( μ M) 3.6 Sauer et al. (2004) Open in a separate window B/P, blood-to-plasma ratio; CL i.v. , clearance after intravenous administration; CL r , renal clearance; F a , fraction absorbed; f m , fraction metabolized; f u , fraction unbound in plasma; k a , absorption rate constant; K i , inhibition constant; Log P, log octanol:water partition coefficient; Q gut , drug absorption flow to intestine; V ss , volume of distribution at steady state. a Mean value (coefficient of variance). .. Physicochemical and PK parameters of atomoxetine used in the PBPK model development Simulation of Atomoxetine Disposition and Validation of the Atomoxetine PBPK Model. All simulations were performed using the Simcyp population-based simulator and a full PBPK model.

Inhibition:

Article Title: Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions
Article Snippet: .. The predicted volume of distribution at steady state (Vss) value was 0.74 l/kg, compared with the observed atomoxetine Vss value of 1.02–1.09 l/kg ( Center for Drug Evaluation and Research, 2002 ) following intravenous dosing in healthy subjects. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Parameter Value Reference Physicochemical Molecular Weight (g/mol) 255.36 Stattera NDA Log P 3.9 NDA p K a 9.8 NDA f u 0.025 NDA B/P 0.623 Simcyp prediction toolbox Absorption F a 0.96 k a (l/h) 1.2 Optimized Q gut (l/h) 11.9 Simcyp prediction toolbox Distribution V ss (l/kg) 0.74 Simcyp prediction full PBPK method 2 Metabolism/elimination CL i.v. (l/h) 16.3 NDA CL r (l/h) 0.185 Sauer et al. (2003) f m,CYP2D6 0.876 Recombinant CL int ( μ l/min/pmol) CYP2D6 25.4 CYP2C19 1.84 P450 enzyme abundance (pmol/mg microsomal protein) CYP2D6 EM 8 (61) a Simcyp default value CYP2C19 EM 14 (40) a Optimized Interaction CYP2D6 K i ( μ M) 34.3 Sauer et al. (2004) CYP3A4 K i ( μ M) 3.6 Sauer et al. (2004) Open in a separate window B/P, blood-to-plasma ratio; CL i.v. , clearance after intravenous administration; CL r , renal clearance; F a , fraction absorbed; f m , fraction metabolized; f u , fraction unbound in plasma; k a , absorption rate constant; K i , inhibition constant; Log P, log octanol:water partition coefficient; Q gut , drug absorption flow to intestine; V ss , volume of distribution at steady state. a Mean value (coefficient of variance). .. Physicochemical and PK parameters of atomoxetine used in the PBPK model development Simulation of Atomoxetine Disposition and Validation of the Atomoxetine PBPK Model. All simulations were performed using the Simcyp population-based simulator and a full PBPK model.



Similar Products

90
Simcyp prediction full pbpk method 2
The workflow of developing and validating the atomoxetine <t>full-PBPK</t> model and extrapolating the validated model to predict atomoxetine disposition in different ethnicities, special populations, and DDIs.
Prediction Full Pbpk Method 2, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prediction+full+pbpk+method+2/method+2/pmc05637815-11-7-6
Average 90 stars, based on 1 article reviews
prediction full pbpk method 2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Simcyp full pbpk model and prediction method 2 simcyp version 13
The workflow of developing and validating the atomoxetine <t>full-PBPK</t> model and extrapolating the validated model to predict atomoxetine disposition in different ethnicities, special populations, and DDIs.
Full Pbpk Model And Prediction Method 2 Simcyp Version 13, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prediction+full+pbpk+method+2/13+compartment+full+pbpk+model+simcyp++population+based+simulator+version+12+1/pm25733027-127-25-31
Average 90 stars, based on 1 article reviews
full pbpk model and prediction method 2 simcyp version 13 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


The workflow of developing and validating the atomoxetine full-PBPK model and extrapolating the validated model to predict atomoxetine disposition in different ethnicities, special populations, and DDIs.

Journal: Drug Metabolism and Disposition

Article Title: Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions

doi: 10.1124/dmd.117.076455

Figure Lengend Snippet: The workflow of developing and validating the atomoxetine full-PBPK model and extrapolating the validated model to predict atomoxetine disposition in different ethnicities, special populations, and DDIs.

Article Snippet: V ss (l/kg) , 0.74 , Simcyp prediction full PBPK method 2.

Techniques:

Physicochemical and PK parameters of atomoxetine used in the  PBPK  model development

Journal: Drug Metabolism and Disposition

Article Title: Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions

doi: 10.1124/dmd.117.076455

Figure Lengend Snippet: Physicochemical and PK parameters of atomoxetine used in the PBPK model development

Article Snippet: V ss (l/kg) , 0.74 , Simcyp prediction full PBPK method 2.

Techniques: Molecular Weight, Recombinant